Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 31, 2013
Grant Date -
Nov 1, 2012
app pub date -
Dec 21, 2011
filing date -
Dec 23, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
Provided is a modified human tumor necrosis factor receptor-1 polypeptide or a fragment thereof that binds to a tumor necrosis factor in vivo or ex vivo. The modified human tumor necrosis factor receptor-1 polypeptide or fragment exhibits improved ability to bind tumor necrosis factor and resistance to proteases.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2011 Application Filing Year
- A61K Class
- 10915 Applications Filed
- 8360 Patents Issued To-Date
- 76.60 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 11 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Dec 17, 2025 |
